N and C-terminal sub-regions in the c-Myc transactivation region and their joint role in creating versatility in folding and binding
- PMID: 15663936
- DOI: 10.1016/j.jmb.2004.11.029
N and C-terminal sub-regions in the c-Myc transactivation region and their joint role in creating versatility in folding and binding
Abstract
The proto-oncogene c-myc governs the expression of a number of genes targeting cell growth and apoptosis, and its expression levels are distorted in many cancer forms. The current investigation presents an analysis by proteolysis, circular dichroism, fluorescence and Biacore of the folding and ligand-binding properties of the N-terminal transactivation domain (TAD) in the c-Myc protein. A c-Myc sub-region comprising residues 1-167 (Myc1-167) has been investigated that includes the unstructured c-Myc transactivation domain (TAD, residues 1-143) together with a C-terminal segment, which appears to promote increased folding. Myc1-167 is partly helical, binds both to the target proteins Myc modulator-1 (MM-1) and TATA box-binding protein (TBP), and displays the characteristics of a molten globule. Limited proteolysis divides Myc1-167 in two halves, by cleaving in a predicted linker region between two hotspot mutation regions: Myc box I (MBI) and Myc box II (MBII). The N-terminal half (Myc1-88) is unfolded and does not alone bind to target proteins, whereas the C-terminal half (Myc92-167) has a partly helical fold and specifically binds both MM-1 and TBP. Although this might suggest a bipartite organization in the c-Myc TAD, none of the N and C-terminal fragments bind target protein with as high affinity as the entire Myc1-167, or display molten globule properties. Furthermore, merely linking the MBI with the C-terminal region, in Myc38-167, is not sufficient to achieve binding and folding properties as in Myc1-167. Thus, the entire N and C-terminal regions of c-Myc TAD act in concert to achieve high specificity and affinity to two structurally and functionally orthogonal target proteins, TBP and MM-1, possibly through a mechanism involving molten globule formation. This hints towards understanding how binding of a range of targets can be accomplished to a single transactivation domain.
Similar articles
-
Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding.Biochemistry. 1996 Jul 23;35(29):9584-93. doi: 10.1021/bi960793v. Biochemistry. 1996. PMID: 8755740
-
B-myc: N-terminal recognition of myc binding proteins.Biochemistry. 2006 Aug 15;45(32):9857-65. doi: 10.1021/bi060379n. Biochemistry. 2006. PMID: 16893186
-
Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).Oncogene. 1999 Jun 24;18(25):3682-95. doi: 10.1038/sj.onc.1202674. Oncogene. 1999. PMID: 10391676
-
The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation.Oncogene. 1999 May 13;18(19):2916-24. doi: 10.1038/sj.onc.1202748. Oncogene. 1999. PMID: 10378688 Review.
-
A moving target: structure and disorder in pursuit of Myc inhibitors.Biochem Soc Trans. 2017 Jun 15;45(3):709-717. doi: 10.1042/BST20160328. Biochem Soc Trans. 2017. PMID: 28620032 Review.
Cited by
-
c-Myc and FOXO3a-The Everlasting Decision Between Neural Regeneration and Degeneration.Int J Mol Sci. 2024 Nov 24;25(23):12621. doi: 10.3390/ijms252312621. Int J Mol Sci. 2024. PMID: 39684331 Free PMC article. Review.
-
Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding.Nucleic Acids Res. 2012 Jul;40(13):6353-66. doi: 10.1093/nar/gks263. Epub 2012 Mar 28. Nucleic Acids Res. 2012. PMID: 22457068 Free PMC article.
-
Unraveling the Behavior of Intrinsically Disordered Protein c-Myc: A Study Utilizing Gaussian-Accelerated Molecular Dynamics.ACS Omega. 2023 Dec 1;9(2):2250-2262. doi: 10.1021/acsomega.3c05822. eCollection 2024 Jan 16. ACS Omega. 2023. PMID: 38250404 Free PMC article.
-
Therapeutic Interventions of Cancers Using Intrinsically Disordered Proteins as Drug Targets: c-Myc as Model System.Cancer Inform. 2017 Mar 16;16:1176935117699408. doi: 10.1177/1176935117699408. eCollection 2017. Cancer Inform. 2017. PMID: 28469390 Free PMC article. Review.
-
MYC on the path to cancer.Cell. 2012 Mar 30;149(1):22-35. doi: 10.1016/j.cell.2012.03.003. Cell. 2012. PMID: 22464321 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases